Catalyst Pharma's total assets for Q2 2025 were $971.91M, an increase of 6.94% from the previous quarter. CPRX total liabilities were $115.89M for the fiscal quarter, a 1.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.